In the BioHarmony Drug Report Database
Oxaliplatin
Eloxatin, Oxaliplatin (oxaliplatin) is a small molecule pharmaceutical. Oxaliplatin was first approved as Eloxatin on 2002-08-09. It is used to treat colorectal neoplasms, ovarian neoplasms, testicular neoplasms, and urinary bladder neoplasms in the USA.
Trade Name
|
Eloxatin, Oxaliplatin |
|---|---|
Common Name
|
oxaliplatin |
ChEMBL ID
|
CHEMBL414804 |
Indication
|
colorectal neoplasms, ovarian neoplasms, testicular neoplasms, urinary bladder neoplasms |
Drug Class
|
Antineoplastics (platinum derivatives) |
Image (chem structure or protein)